Company · ANIX
Anixa Biosciences, Inc.
Name as listed on its exchange; filed with the SEC as Anixa Biosciences Inc.
Nasdaq's symbol directory lists ANIX on Nasdaq as “Anixa Biosciences, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 18 occasions ($491K).
All insider filings at the SEC · Appeared in No. 35, No. 34, No. 33, No. 32, No. 31, No. 30, No. 29
Insider purchases above the line: $491KInsider sales below: $0
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Lewis H. Titterton Jr. bought $241K
- Amit Kumar, Chief Executive Officer bought $221K
- Catelani Michael, President, COO, & CFO bought $16K
- Arnold M. Baskies bought $14K
Every trade (18)
- BUYAmit Kumar, Chief Executive Officer bought $16K
- BUYLewis H. Titterton Jr. bought $24K
- BUYAmit Kumar, Chief Executive Officer bought $22K
- BUYCatelani Michael, President, COO, & CFO bought $16K
- BUYAmit Kumar, Chief Executive Officer bought $19K
- BUYArnold M. Baskies bought $14K
- BUYLewis H. Titterton Jr. bought $132K
- BUYLewis H. Titterton Jr. bought $27K
- BUYAmit Kumar, Chief Executive Officer bought $22K
- BUYAmit Kumar, Chief Executive Officer bought $17K
- BUYAmit Kumar, Chief Executive Officer bought $28K
- BUYAmit Kumar, Chief Executive Officer bought $11K
- BUYLewis H. Titterton Jr. bought $42K
- BUYAmit Kumar, Chief Executive Officer bought $17K
- BUYLewis H. Titterton Jr. bought $9K
- BUYAmit Kumar, Chief Executive Officer bought $15K
- BUYLewis H. Titterton Jr. bought $7K
- BUYAmit Kumar, Chief Executive Officer bought $52K
Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.